Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 3Gynecologic 2Dermatologic 1

Conditions

Keratosis, Actinic 29Carcinoma, Basal Cell 12Melanoma 10Keratosis 4Neoplasm Metastasis 2Skin Neoplasms 1Precancerous Conditions 1Lymphoma, T-Cell, Cutaneous 1Leukoplakia 1Leukokeratosis, Hereditary Mucosal 1Hutchinson's Melanotic Freckle 1Facies 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Cyclosporine 4Antilymphocyte Serum 4Aminolevulinic Acid 4Whole-Body Irradiation 3Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Etoposide 3Epoetin Alfa 3Darbepoetin alfa 3Busulfan 3Sirolimus 2Morphine 2Methylprednisolone 2Melphalan 2Filgrastim 2Biopsy 2tremelimumab 1tirbanibulin 1pyroxamide 1perillyl alcohol 1ferrous sulfate 1ferric gluconate 1arginine butyrate 1Triamcinolone 1Therapeutics 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Imiquimod × Dermatologic × Clear all
NCT00175643 2006-05-09

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

University of British Columbia

Phase 3 Completed
20 enrolled
DermatologicOther neoplasm

Carcinoma, Squamous Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡